Quantum Biopharma (QNTM) EPS (Basic) Growth (1y) (2020 - 2026)
Quantum Biopharma (QNTM) EPS (Basic) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | -16.29% |
| 10 | Quantum Biopharma | 15.53 Mn | 11.89 Mn | - | 82.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.21% |
| Mar 31, 2026 | 52.71% |
| Dec 31, 2025 | 85.41% |
| Sep 30, 2025 | 66.30% |
| Jun 30, 2025 | -1,858.27% |
| Mar 31, 2025 | 61.40% |
| Dec 31, 2024 | 91.60% |
| Sep 30, 2024 | 100.00% |
| Jun 30, 2024 | 100.00% |
| Mar 31, 2024 | 79.23% |
| Mar 31, 2023 | -1,886.93% |
| Mar 31, 2022 | -164.09% |
| Jun 30, 2021 | -1,401,865.65% |
| Mar 31, 2021 | 118.04% |
| Sep 30, 2020 | 62.92% |
| Jun 30, 2020 | 73.65% |
| Mar 31, 2020 | 10.67% |